Back

Effect of TTR stabilisers on strain values derived by echocardiography in patients with wild type ATTR Amyloidosis

17 May 2025 (08:00 - 12:45)
Organised by: Logo
Congress Presentation Part of: ePosters in myocardial disease - hypertrophic cardiomyopathy (2) Hypertrophic Cardiomyopathy HFA Premium Access Heart Failure 2025 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Julian Georg Westphal

University Hospital of Jena, Jena (Germany)

7 More presentations in this session

Presentation thumbnail
Recognizing red flags: don't judge a book by its cover. data from a multicentric nationwide study
Doctor A. Pinho (Porto, PT)
Abstract Slides Video
Presentation thumbnail
Mavacamten use in a real-world cohort of obstructive hypertrophic cardiomyopathy patients: insights from the initial centre experience
Doctor M. Lima (Lisbon, PT)
Abstract Slides Video
Presentation thumbnail
Estimating hypertrophic cardiomyopathy genotype pre-test probability: an online calculator
Mr P. Kopp (Stony Brook, US)
Abstract Slides Video
Presentation thumbnail
Differentiating clinical trial endpoints in transthyretin cardiac amyloidosis is significantly improved with continuing medical education
Doctor C. Rohani-Montez (London, GB)
Abstract Slides Video
Presentation thumbnail
Changes in global myocardial work indices during mavacamten treatment in obstructive hypertrophic cardiomyopathy
Professor R. Sepp (Szeged, HU)
Abstract Slides Video

Access the full session

Session thumbnail
ePosters in myocardial disease - hypertrophic cardiomyopathy (2)

The Event

Event poster

Heart Failure 2025

17 May - 20 May 2025
You may be interested in
thumbnail
Congress Presentation
Evolution over time of cardiac biomarkers, electrocardiographic and echocardiographic features in a large cohort of patients with wild-type transthyretin cardiac amyloidosis treated with tafamidis
thumbnail
Congress Presentation
Basal inferior-septal segment is highly susceptible to deformation in the clinical spectrum of transthyretin-derived cardiomyopathy
thumbnail
Congress Presentation
Improvement of ventricular dysfunction in transthyretin cardiac amyloidosis after short-term treatment with Tafamidis - Strain can be the best monitoring tool?

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources